HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · Ver en SEC EDGAR ↗
$417,32
Precio · Ago 18, 2026
Fundamentales a fecha de Jul 28, 2026

Acerca de HCA Healthcare, Inc. Common Stock Descripción general de la empresa de Wikipedia

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

Leer más

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

HCA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$417.32
Capitalización Bursátil
$93.73B
P/E (TTM)
14.7
BPA (TTM)
$28.33
Ingresos (TTM)
$75.60B
Rendimiento div.
0.73%
ROE
-159.1%
Deuda/Capital
-6.9
Rango 52S
$354 – $557

HCA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
BPA $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
Flujo de caja libre $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
Márgenes 9.0%

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
HCA
Mediana de Pares
P/E (TTM)
5-point trend, +35.7%
14.7
20.3
P/S (TTM) (P/V (TTM))
5-point trend, +3.8%
1.2
1.1
P/B (P/C)
5-point trend, +79.3%
-15.6
4.5
EV / EBITDA
5-point trend, +5.5%
38.1
Price / FCF (Precio / FCF)
5-point trend, -6.5%
12.2

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
HCA
Mediana de Pares
Net Profit Margin (Margen de Beneficio Neto)
5-point trend, -24.2%
9.0%
7.4%
ROA
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
HCA
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
5-point trend, +81.4%
-6.9
Current Ratio (Ratio corriente)
5-point trend, -31.7%
1.0
1.2
Quick Ratio (Ratio Rápido)
5-point trend, -26.9%
0.7

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
HCA
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y (Ingresos CAGR 3A)
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y (Ingresos CAGR 5A)
5-point trend, +28.7%
8.0%
EPS YoY (EPS interanual)
5-point trend, +33.9%
28.8%
Net Income YoY (Beneficio Neto interanual)
5-point trend, -2.5%
17.8%

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
HCA
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
5-point trend, +33.9%
$28.33

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
HCA
Mediana de Pares
Payout Ratio (Ratio de Pago)
5-point trend, +11.6%
10.0%

Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años

Rendimiento por Dividendo
0.73%
Ratio de Pago
10.0%
CAGR de Dividendos a 5 años
Fecha ex-dividendoMonto
16 de junio de 2026$0,7800
17 de marzo de 2026$0,7800
15 de diciembre de 2025$0,7200
16 de septiembre de 2025$0,7200
16 de junio de 2025$0,7200
17 de marzo de 2025$0,7200
13 de diciembre de 2024$0,6600
16 de septiembre de 2024$0,6600
14 de junio de 2024$0,6600
14 de marzo de 2024$0,6600
13 de diciembre de 2023$0,6000
14 de septiembre de 2023$0,6000
15 de junio de 2023$0,6000
16 de marzo de 2023$0,6000
13 de diciembre de 2022$0,5600
15 de septiembre de 2022$0,5600
15 de junio de 2022$0,5600
16 de marzo de 2022$0,5600
13 de diciembre de 2021$0,4800
15 de septiembre de 2021$0,4800

HCA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 30 analistas
  • Compra fuerte 6 20,0%
  • Compra 11 36,7%
  • Mantener 12 40,0%
  • Venta 1 3,3%
  • Venta fuerte 0 0,0%

Precio objetivo a 12 meses

21 analistas · 2026-08-17
Objetivo mediano $450.00 +7,8%
Objetivo medio $454.57 +8,9%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.49%
Período EPS Actual EPS est. Sorpresa
30 de junio de 2026 $7.62 $7.54 0.08%
31 de marzo de 2026 $7.15 $7.21 -0.06%
31 de diciembre de 2025 $8.14 $7.53 0.61%
30 de septiembre de 2025 $6.96 $5.77 1.2%
30 de junio de 2025 $6.83 $6.31 0.52%
31 de marzo de 2025 $6.45 $5.84 0.61%

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SGRY $2.00B -25.3 6.2% -2.4% -4.5%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 12
Datos anuales de Estado de resultados para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Balance general 22
Datos anuales de Balance general para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
Flujo de Efectivo 17
Datos anuales de Flujo de Efectivo para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
Rentabilidad 5
Datos anuales de Rentabilidad para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
Liquidez y Solvencia 4
Datos anuales de Liquidez y Solvencia para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
Eficiencia 2
Datos anuales de Eficiencia para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
Por Acción 6
Datos anuales de Por Acción para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Tasas de Crecimiento 10
Datos anuales de Tasas de Crecimiento para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
Valoración (TTM) 17
Datos anuales de Valoración (TTM) para HCA
Métrica Tendencia 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $75.60B$70.60B$64.97B$60.23B$58.75B
Beneficio neto $6.78B$5.76B$5.24B$5.64B$6.96B
EPS Diluido $28.33$22.00$18.97$19.15$21.16
Balance general
2025-12-312024-12-312023-12-312022-12-312021-12-31
Deuda / Patrimonio -6.9-17.2-22.3-13.8-37.1
Ratio corriente 1.01.11.21.41.4
Ratio Rápido 0.70.80.91.01.0
Flujo de Efectivo
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flujo de caja libre $7.69B$5.64B$4.69B$4.13B$5.38B

Últimas noticias Noticias recientes que mencionan a esta empresa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Propietarios institucionales (13F) 1 486 declarantes · $39.4B total · A fecha de 30 de junio de 2026

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
128 (-51 vs trimestre anterior) 174 (+70 vs trimestre anterior) 450 (-30 vs trimestre anterior) 555 (-4 vs trimestre anterior) +16.3M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
VANGUARD GROUP INC $6 118 113 464 13 104 814 15,52% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $3 954 150 533 10 141 708 10,03% Acciones
Sanders Capital, LLC $3 442 060 818 8 828 287 8,73% Acciones
STATE STREET CORP $2 912 102 056 7 469 035 7,39% Acciones
WELLINGTON MANAGEMENT GROUP LLP $1 750 298 867 4 489 212 4,44% Acciones
GEODE CAPITAL MANAGEMENT, LLC $1 225 259 672 3 159 159 3,11% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $1 057 704 509 2 712 828 2,68% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861 456 107 2 209 485 2,19% Acciones
NORGES BANK $836 457 140 2 145 367 2,12% Acciones
Capital World Investors $770 864 224 1 977 121 1,96% Acciones
Capital International Investors $747 403 041 1 916 947 1,90% Acciones
Crake Asset Management LLP $449 072 183 1 151 792 1,14% Acciones
Metropolis Capital Ltd $430 915 307 910 564 1,09% Acciones
Darsana Capital Partners LP $428 879 000 1 100 000 1,09% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414 533 777 1 063 207 1,05% Acciones
Life Cycle Investment Partners Ltd $355 737 196 912 404 0,90% Acciones
VANGUARD FIDUCIARY TRUST CO $339 685 814 871 235 0,86% Acciones
FMR LLC $325 199 295 834 080 0,83% Acciones
BARCLAYS PLC $299 888 573 769 162 0,76% Acciones
LYRICAL ASSET MANAGEMENT LP $255 015 742 654 071 0,65% Acciones
BlackRock, Inc. $240 062 291 615 718 0,61% Acciones
ROYAL LONDON ASSET MANAGEMENT LTD $235 649 908 604 401 0,60% Acciones
National Pension Service $230 650 346 591 578 0,59% Acciones
NORDEA INVESTMENT MANAGEMENT AB $230 189 125 594 466 0,58% Acciones
GOLDMAN SACHS GROUP INC $209 775 669 538 038 0,53% Acciones
Gobi Capital LLC $195 742 325 502 045 0,50% Acciones
Cryder Capital Partners LLP $194 561 738 499 017 0,49% Acciones
Swiss National Bank $172 097 446 441 400 0,44% Acciones
AustralianSuper Pty Ltd $159 635 782 409 438 0,41% Acciones
Consulta Ltd $155 956 000 400 000 0,40% Acciones
LEE DANNER & BASS INC $152 150 679 390 240 0,39% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151 472 265 388 500 0,38% Opción de compra
Mitsubishi UFJ Asset Management Co., Ltd. $147 943 761 379 450 0,38% Acciones
DIMENSIONAL FUND ADVISORS LP $139 697 405 358 300 0,35% Acciones
Vanguard Global Advisers, LLC $136 962 509 351 285 0,35% Acciones
VIRGINIA RETIREMENT SYSTEMS ET Al $134 838 505 288 820 0,34% Acciones
ALLIANCEBERNSTEIN L.P. $134 459 788 284 126 0,34% Acciones
Sumitomo Mitsui Trust Group, Inc. $132 794 974 340 596 0,34% Acciones
TD Asset Management Inc $131 847 152 338 165 0,33% Acciones
Legal & General Group Plc $127 805 162 327 798 0,32% Acciones
California Public Employees Retirement System $124 133 958 318 382 0,31% Acciones
LAZARD ASSET MANAGEMENT LLC $120 619 879 309 369 0,31% Acciones
JANE STREET GROUP, LLC $119 540 274 306 600 0,30% Opción de compra
VANGUARD ASSET MANAGEMENT, Ltd $116 069 863 297 699 0,29% Acciones
CAPTRUST FINANCIAL ADVISORS $114 741 071 294 291 0,29% Acciones
ANTIPODES PARTNERS Ltd $113 045 096 289 941 0,29% Acciones
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109 718 328 231 845 0,28% Acciones
CITADEL ADVISORS LLC $105 660 190 271 000 0,27% Opción de compra
RHUMBLINE ADVISERS $97 580 413 250 277 0,25% Acciones
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97 026 076 248 855 0,25% Acciones
MACKENZIE FINANCIAL CORP $93 597 383 240 061 0,24% Acciones
BloombergSen Inc. $93 160 317 238 940 0,24% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92 247 974 236 600 0,23% Opción de venta
Brandywine Global Investment Management, LLC $89 380 814 191 451 0,23% Acciones
BANK OF AMERICA CORP /DE/ $89 069 981 228 449 0,23% Acciones
NEUBERGER BERMAN GROUP LLC $85 926 216 220 386 0,22% Acciones
MILFORD FUNDS LTD $82 165 029 210 739 0,21% Acciones
Bridgewater Associates, LP $79 227 208 203 204 0,20% Acciones
Prana Capital Management, LP $75 552 494 193 779 0,19% Acciones
DANSKE BANK A/S $73 238 497 187 844 0,19% Acciones
FRANKLIN RESOURCES INC $70 965 828 182 015 0,18% Acciones
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70 445 715 180 681 0,18% Acciones
Quantinno Capital Management LP $70 407 055 180 581 0,18% Acciones
ARGENT CAPITAL MANAGEMENT LLC $69 149 681 177 357 0,18% Acciones
Retirement Systems of Alabama $68 081 812 174 618 0,17% Acciones
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66 167 842 169 709 0,17% Acciones
BNP PARIBAS FINANCIAL MARKETS $64 793 090 166 183 0,16% Acciones
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64 665 206 165 855 0,16% Acciones
HSBC HOLDINGS PLC $64 431 534 165 332 0,16% Acciones
AVIVA PLC $64 264 789 164 828 0,16% Acciones
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64 194 533 135 649 0,16% Acciones
SEB Asset Management AB $63 257 255 162 244 0,16% Acciones
TODD ASSET MANAGEMENT LLC $62 567 208 160 474 0,16% Acciones
Swedbank AB $62 528 998 160 376 0,16% Acciones
W1M Investment Management Ltd $61 247 490 143 647 0,16% Acciones
HARRIS ASSOCIATES L P $60 080 879 154 097 0,15% Acciones
Ensign Peak Advisors, Inc $58 372 381 149 715 0,15% Acciones
NEW YORK STATE COMMON RETIREMENT FUND $57 747 778 148 113 0,15% Acciones
CITADEL ADVISORS LLC $57 235 852 146 800 0,15% Opción de venta
Universal- Beteiligungs- und Servicegesellschaft mbH $57 160 993 146 800 0,15% Acciones
LOS ANGELES CAPITAL MANAGEMENT LLC $56 512 217 144 944 0,14% Acciones
Pictet Asset Management Holding SA $52 147 803 133 739 0,13% Acciones
VICTORY CAPITAL MANAGEMENT INC $50 752 761 130 172 0,13% Acciones
Pentwater Capital Management LP $50 685 700 130 000 0,13% Acciones
D. E. Shaw & Co., Inc. $50 554 307 129 663 0,13% Acciones
APG Asset Management N.V. $50 368 550 147 699 0,13% Acciones
AMF Tjanstepension AB $50 355 853 129 154 0,13% Acciones
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50 349 225 129 137 0,13% Acciones
EQUITABLE TRUST CO $49 147 974 126 056 0,12% Acciones
ENVESTNET ASSET MANAGEMENT INC $48 919 124 125 469 0,12% Acciones
CANADA PENSION PLAN INVESTMENT BOARD $48 197 812 123 619 0,12% Acciones
AMERICAN CENTURY COMPANIES INC $47 460 140 121 727 0,12% Acciones
OpenArc Corporate Advisory, LLC $47 210 610 121 087 0,12% Acciones
L1 Capital International Pty Ltd $46 121 648 118 294 0,12% Acciones
FIRST TRUST ADVISORS LP $44 251 579 113 498 0,11% Acciones
PFA Pension, Forsikringsaktieselskab $44 046 098 112 971 0,11% Acciones
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43 830 264 112 417 0,11% Acciones
EP Wealth Advisors, LLC $43 287 826 111 026 0,11% Acciones
WOLVERINE TRADING, LLC $42 597 104 101 200 0,11% Opción de compra
MERCER GLOBAL ADVISORS INC /ADV $42 302 070 108 497 0,11% Acciones

Informantes de la empresa 91 insiders · 54 directivos · 31 consejeros

Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Samuel N Hazen CEO 10 de febrero de 2026 F 64 842 0 7 $-21 483 290
O'Boyle Michael P President & CEO - Parallon 26 de febrero de 2013 A 21 429 0 0 $0
Mike A Marks EVP and CFO 7 de mayo de 2026 G 46 576 0 0 $0
Bill B Rutherford CFO and EVP 16 de febrero de 2024 F 22 251 0 0 $0
Russell K Harms CFO - Central Group 17 de noviembre de 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 de noviembre de 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 de noviembre de 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 1 de julio de 2005 F 13 865 0 0 $0
Erol R Akdamar Group President 12 de noviembre de 2024 M 6 843 0 0 $0
Timothy M Mcmanus Group President 31 de julio de 2024 M 27 008 0 0 $0
Richard A Hammett Group President 16 de febrero de 2024 F 17 936 0 0 $0
Charles J Hall Group President 11 de noviembre de 2022 M 202 443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 de noviembre de 2022 S 30 807 0 0 $0
Paul W Rutledge Group President 31 de diciembre de 2012 A 335 657 0 0 $0
Beverly B Wallace President - Parallon 2 de noviembre de 2011 M 144 714 0 0 $0
Charles Robert Evans President - Eastern Group 26 de julio de 2006 A 62 173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 de octubre de 2005 A 26 154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 de octubre de 2004 D 9 029 0 0 $0
Jay Grinney President-Eastern Group 7 de mayo de 2004 D 24 177 0 0 $0
Jon M Foster EVP and COO 10 de febrero de 2026 F 23 062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 13 de febrero de 2026 M 8 853 0 2 $-2 747 520
Jennifer Berres SVP & Chief Human Res. Officer 11 de febrero de 2026 S 11 993 0 2 $-4 126 932
Christopher F. Wyatt SVP & Controller 11 de febrero de 2026 S 44 379 0 1 $-2 020 000
Erica Rossitto SVP & Chief Nurse Executive 10 de febrero de 2026 F 10 407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 de febrero de 2026 F 32 080 0 1 $-747 135
Sammie S Mosier SVP & Chief Nurse Executive 13 de febrero de 2025 F 11 113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 de noviembre de 2024 S 9 454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 de noviembre de 2024 M 52 702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 5 de agosto de 2024 G 18 526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 de julio de 2024 S 3 510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 de julio de 2024 S 17 755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 9 de mayo de 2024 S 5 185 0 0 $0
Chad J Wasserman SVP and CIO 18 de marzo de 2024 M 1 576 0 0 $0
Martin P. Paslick SVP and CIO 12 de abril de 2023 M 24 643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 9 de noviembre de 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 5 de mayo de 2021 S 50 062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 de febrero de 2021 F 5 578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 de febrero de 2021 F 10 122 0 0 $0
Victor L Campbell SVP-Government Affairs 1 de mayo de 2019 A 194 145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 de febrero de 2019 M 84 157 0 0 $0
Milton R Johnson Chairman 25 de febrero de 2019 M 881 823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 de febrero de 2018 M 7 003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 de febrero de 2018 M 35 546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 de febrero de 2018 M 65 199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 de mayo de 2017 M 26 378 0 0 $0
David Gwin Anderson SVP - Finance 7 de noviembre de 2016 M 110 167 0 0 $0
Donald W Stinnett SVP & Controller 25 de febrero de 2016 A 51 965 0 0 $0
Noel B Williams SVP and CIO 16 de mayo de 2012 M 299 030 0 0 $0
Jack O Bovender JR Chairman 6 de octubre de 2009 A 188 340 0 0 $0
Carl V George SVP - Development 27 de febrero de 2009 M 13 092 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Activistas y propietarios del %+ 5 4 tenencias

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 de febrero de 2026 31,60% Presentación inicial SEC
22 de noviembre de 2006 Presentación inicial SEC
Merrill Lynch Bank USA 11 de septiembre de 2006 Presentación inicial SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 4 de agosto de 2006 Presentación inicial SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Propiedad de ETFs Mantenido por 207 ETFs

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
IHF · iShares Trust 4,67% 141 320 SH 8 de agosto de 2026 Diario
BUL · Pacer Funds Trust 3,91% 11 437 NS 30 de abril de 2026 N-PORT
YALL · Tidal Trust I 3,61% 9 261 NS 31 de mayo de 2026 N-PORT
BWTG · ETF Opportunities Trust 3,02% 1 646 NS 31 de mayo de 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,32% 99 335 SH 8 de agosto de 2026 Diario
ABIG · EA Series Trust 2,00% 2 938 NS 29 de mayo de 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,99% 39 985 NS 30 de abril de 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,67% 31 685 SH 8 de agosto de 2026 Diario
COWZ · Pacer Funds Trust 1,64% 688 264 NS 30 de abril de 2026 N-PORT
QQWZ · Pacer Funds Trust 1,64% 1 762 NS 30 de abril de 2026 N-PORT
FEGE · RBB Fund Trust 1,46% 74 706 NS 31 de mayo de 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1,39% 60 385 SH 8 de agosto de 2026 Diario
RPG · Invesco Exchange-Traded Fund Trust 1,30% 63 448 SH 8 de agosto de 2026 Diario
TMFE · RBB Fund, Inc. 1,29% 2 892 NS 31 de mayo de 2026 N-PORT
AMID · EA Series Trust 1,23% 3 402 NS 29 de mayo de 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,15% 7 180 NS 30 de abril de 2026 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1,12% 6 544 NS 30 de abril de 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,12% 73 639 NS 30 de abril de 2026 N-PORT
SRHQ · Elevation Series Trust 1,10% 4 883 NS 30 de abril de 2026 N-PORT
IYH · iShares Trust 0,99% 89 420 SH 8 de agosto de 2026 Diario
NEAR · iShares U.S. ETF Trust 0,99% 48 109 000 SH 8 de agosto de 2026 Diario
CURE · Direxion Shares ETF Trust 0,98% 3 122 NS 30 de abril de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470 451 SH 8 de agosto de 2026 Diario
NFRA · FlexShares Trust 0,88% 62 176 NS 30 de abril de 2026 N-PORT
REVS · Columbia ETF Trust I 0,87% 5 693 NS 30 de abril de 2026 N-PORT
RXL · ProShares Trust 0,86% 1 632 NS 31 de mayo de 2026 N-PORT
DIVB · iShares Trust 0,85% 36 806 SH 8 de agosto de 2026 Diario
BSCT · Invesco Exchange-Traded Self-Indexe… 0,82% 24 078 000 8 de agosto de 2026 Diario
LSEQ · Harbor ETF Trust 0,81% 285 NS 30 de abril de 2026 N-PORT
IXJ · iShares Trust 0,80% 81 465 SH 8 de agosto de 2026 Diario
BSCS · Invesco Exchange-Traded Self-Indexe… 0,76% 26 493 000 8 de agosto de 2026 Diario
SPVM · Invesco Exchange-Traded Fund Trust 0,74% 2 335 SH 8 de agosto de 2026 Diario
FTC · First Trust Exchange-Traded AlphaDE… 0,73% 21 329 NS 30 de abril de 2026 N-PORT
RFFC · ALPS ETF Trust 0,68% 533 NS 31 de mayo de 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0,68% 2 698 NS 30 de abril de 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12 075 SH 8 de agosto de 2026 Diario
VCEB · VANGUARD WORLD FUND 0,62% 8 146 000 PA 8 de agosto de 2026 Diario
FDMO · FIDELITY COVINGTON TRUST 0,61% 11 771 NS 30 de abril de 2026 N-PORT
RECS · Columbia ETF Trust I 0,58% 72 768 NS 30 de abril de 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0,56% 9 664 NS 31 de mayo de 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11 876 SH 8 de agosto de 2026 Diario
VLLU · Harbor ETF Trust 0,54% 54 NS 30 de abril de 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0,53% 7 404 NS 30 de abril de 2026 N-PORT
WLDR · Two Roads Shared Trust 0,51% 844 NS 30 de abril de 2026 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0,50% 4 620 NS 31 de mayo de 2026 N-PORT
AKAF · ETF Series Solutions 0,50% 39 NS 31 de mayo de 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22 679 000 8 de agosto de 2026 Diario
ROUS · Lattice Strategies Trust 0,47% 6 388 NS 30 de abril de 2026 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0,46% 54 218 000 PA 8 de agosto de 2026 Diario
CGGR · Capital Group Growth ETF 0,45% 290 273 NS 31 de mayo de 2026 N-PORT